RxDoctor Payments Data

Howard Goodman, MD

Orthopaedic Surgery · Brooklyn, NYNPI 1740477934

Payments from drug & device makers

What this record shows

Carbofix Orthopedics Inc accounts for 80.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $1,908 and has fallen 81.8% since, to $348 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$3,000in general payments, 2019–2025

Across 19 payments — averaging $157.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Carbofix Orthopedics Inc$2K
  • DJO, LLC$146
  • Onkos Surgical, Inc.$129
  • Bone Support Inc.$107
  • Bonalive Inc$75
  • GSK$71
  • plus $63 from 1 others

What the payments were for

  • Travel & lodging$1,55952%
  • Food & beverage$1,44148%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Carbofix Orthopedics Inc10$2,408
DJO, LLC1$146
Onkos Surgical, Inc.1$129
Bone Support Inc.1$107
Bonalive Inc1$75
GSK3$71
Stryker2$63

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,000 in reported general payments places this provider in the 40th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$211,633
Medicare patients
252
Services billed
969

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin22$130

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Brooklyn

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →